Three Years Follow Up Of The ARIS™ Trans-Obturator Tape
Main Category: Urology / NephrologyArticle Date: 11 Nov 2008 - 1:00 PDT
MONTEREY, CA, USA (UroToday.com) - Dr. Saad Juma presented his experience in 234 patients who had completed a 12 to 26 month (mean 23.3) questionnaire follow up after placement of an Aris™ transobuturator sling. The group reported resolution of SUI in 90.61% of the patients, of urge incontinence in 61.81%, and only 2.51% (n=2) with de novo urgency symptoms.
Each of the questionnaires used in the study, the Urogenital Distress Inventory (UDI-6), the Incontinence Impact Questionnaire (IIQ-7), and the Global Symptom Index, showed statistically significant improvements from pre- to post-operative assessment.
Complications were minimal and included vaginal tape extrusion in 1.3% (n=3), urinary tract infection in 0.9% (n=2), and necessity for tape release for treatment of BOO in 0.9% (n=2).
Presented by Saad Juma, MD, at the 84th Annual Meeting of the AUA - Western Section - October 26 - 30, 2008 - Monterey, California
Reported by Alvaro Lucioni, MD, Virginia Mason Medical Center, Seattle, WA.
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2008 - UroToday
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |




